(Press-News.org)
Streptococcus pyogenes or invasive Group A Streptococcus (iGAS) is a major clinical concern around the world, since iGAS infections can quickly escalate into life-threatening conditions such as necrotizing fasciitis, septic shock, and pneumonia. In recent years, scientists have noticed that the prevalence of various pathological strains of iGAS has been evolving. Before the COVID-19 pandemic, the prevalent strain in Western Europe was Emm1. However, in the last five years, a potentially more virulent strain called M1uk has been seen in several European countries. It is not clear whether public health systems need to change their response to iGAS infections in the face of these developments.
To understand the evolving epidemiology of iGAS infections, researchers from Spain and France conducted a retrospective study of 68 patients admitted with iGAS to the ICU of Donostia University Hospital between 2010 and 2024. This research project was led by Dr. Milagrosa Montes, Dr. Loreto Vidaur, and Dr. Jordi Rello, as part of the interdisciplinary project on Pneumonia from the Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Spain. Their findings were made available online on September 1, 2025 and will be published in an upcoming issue of the Journal of Intensive Medicine.
The team documented waves of infections with peaks in 2014, 2019, and 2023, and sharp declines during 2020–2021, associated with the mitigation strategies for COVID-19. A key finding was the distribution of different serotypes. While emm1 was the most frequently isolated strain, the study also documented a range of serotypes associated with both respiratory and soft tissue infections. Monitoring this diversity is crucial, as shifts in dominant strains may alter the efficacy of potential vaccines that target limited serotype groups.
Dr. Montes explained: “Although emm1 remains the most common in our ICU population, the presence of other serotypes highlights the need for ongoing vigilance. Serotype diversity matters because it can influence not only outbreak dynamics but also it can affect the effectiveness of vaccine candidates that target limited serotype groups”
As seen in other countries, the highly toxigenic M1uk lineage became prevalent in recent years and was found in 85% of patients treated for iGAS in 2023. Internationally, this variant has raised concern due to its role in pediatric scarlet fever outbreaks. Yet, the team found that M1uk does not worsen prognosis in critically ill adults.
“M1uk patients tended to be older, but their mortality rates were similar to those infected with other strains,” said Dr. Vidaur. “This finding reassures both clinicians and policymakers: the rise of M1uk does not translate into higher death rates in ICU settings.”
Perhaps the most clinically relevant result of the study concerns clindamycin. Early clindamycin administration, in combination with beta-lactams, suppressed streptococcal toxin production and was associated with significantly better outcomes. This practice became routine after the COVID-19 pandemic, reducing median clindamycin administration time from 24 hours to just 1 hour after admission. Mortality rates fell accordingly.
Conversely, patients who did not receive clindamycin promptly faced up to five times greater ICU mortality. “Ensuring that clindamycin is part of the first-line emergency treatment for suspected iGAS should be a priority,” stressed Dr. Rello.
Improvements in treatment protocols brought down overall mortality from 25.5% in the pre-pandemic years to 10% after 2022, despite changes in serotype distribution. This highlights the need for maintaining robust epidemiological surveillance of circulating strains and prioritizing timely, evidence-based treatment. While the diversity of S. pyogenes serotypes may reduce the potential effectiveness of vaccines in development, continuous surveillance and immediate clindamycin administration remain the most effective interventions to monitor spread and reduce mortality.
“This research reminds us that vigilance must be twofold,” concluded Dr. Vidaur. “We must continue to monitor serotype evolution for public health reasons, but at the patient level, the speed and appropriateness of treatment remain the decisive factors.”
By combining epidemiological awareness with prompt therapeutic action, clinicians can continue to improve survival in one of the most dangerous bacterial infections in critical care medicine.
***
Reference
DOI: 10.1016/j.jointm.2025.06.001
About Professor Jordi Rello
Dr. Jordi Rello is a Professor at the Global Health eCore, Vall d’Hebron University Hospital Campus, Barcelona, Spain. After obtaining his M.D.-Ph.D. degree in infectious diseases, he focused his research interests on intensive and critical care medicine, sepsis management, and immunology of infectious diseases. Over the last 35 years, he has published more than 700 research articles that have been cited over 60,000+ times. He is a key opinion leader in the area of intensive care medicine and has won several international awards for his excellence in research.
About Dr. Loreto Vidaur
Dr. Loreto Vidaur is an internationally recognized specialist in Intensive Care Medicine, working at the Donostia University Hospital in Donostia, Spain. She is known for her impactful research on infectious diseases and pneumonia in critically ill patients. Dr. Vidaur’s scientific publications have influenced global protocols and advanced clinical practice, improving outcomes in severe respiratory infections. She currently provides expert care in the Intensive Care Unit, bringing her research directly into patient treatment and inspiring the international scientific community.
END
PRESS EMBARGO! NOT FOR RELEASE UNTIL THURSDAY NOVEMBER 6 AT 12H00 NOON GMT
Three new toad species skip the tadpole phase and give birth to live toadlets
An international team of researchers have identified three new species of enchanting, pustular, tree-dwelling toads from Africa. Their solution for having offspring away from water? Skipping the tadpole phase altogether, and giving birth to live toadlets. The study is published today in the open access scientific journal Vertebrate Zoology.
Most textbooks ...
About The Study: The findings of this study confirm that negative reinforcement is a core mechanism in opioid addiction, which is well established in preclinical research but less represented in treatment. Importantly, it is not limited to the later stages of addiction but is even observed after regular opioid use, potentially contributing to the development of addiction, which may have important implications for the development of more effective preventive and therapeutic interventions.
Corresponding Author: To contact the corresponding author, Karen D. Ersche, PhD, email ke220@cam.ac.uk.
To ...
RODIN - Cell-mediated Sculptable Living Platforms-, is set to revolutionize the field of biomaterials and tissue engineering by shifting the focus from designing materials for cells to empowering cells to design their own environments. The team composed by Professor João Mano at the Associate Laboratory CICECO – Aveiro Institute of Materials from University of Aveiro (Portugal) - The Biomaterials Engineer, Professor Tom Ellis at Imperial College London (UK)- The Synthetic Biologist and Professor Nuno Araújo at Faculty of Sciences, from the University of Lisbon (Portugal)- The Physicist, will combine expertise to rethink how living ...
Diagnosing and treating tumors in real time during endoscopy, with theragnostics: the tumor is identified and characterized with a high-resolution ‘optical biopsy’ and, at the same time, treated with ‘cold plasma’ (that does not involve thermal energy and is therefore much safer). This is the core of ‘MULTIPROBE’, a multicenter project conducted by researchers from the Università Cattolica del Sacro Cuore, campus di Roma, Fondazione Universitaria Policlinico Agostino Gemelli IRCCS, Sapienza Università di Roma, and the University of Limoges, France, which won the prestigious ERC Synergy Grant 2025 research ...
Professors Jun Borras, Esteve Corbera, Ian Scoones and Anna Tsing, working at universities in the Netherlands, Spain, the UK and Denmark, have been awarded an €8.33 million European Research Council (ERC) Synergy Grant for their five-year project, Land and Life in the Anthropocene: Landscape reform (LAND). The project asks a pressing question: How can we learn to live on Earth in new ways?
The innovation of the project is to move from land reform to landscape reform, that is, liveable and justice-based transformations for more-than-human life. LAND starts from the recognition that economies, politics, social ...
A new study led by researchers at the University of Hawai‘i (UH) at Mānoa published today in Nature Communications is the first of its kind to show that waste discharged from deep-sea mining operations in the Pacific’s biodiverse Clarion-Clipperton Zone (CCZ) could disrupt marine life in the midwater “twilight zone” — a vital region 200-1,500 meters below sea level that supports vast communities of zooplankton, tiny animals that serve as the ocean’s basic food building blocks. Specifically, it finds that 53% of all zooplankton and 60% of micronekton, which feed on zooplankton, would be impacted by the discharge, which could ...
BALTIMORE, MD., November 6, 2025--Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) reported encouraging results from an early phase clinical trial that found an experimental intranasal vaccine triggered a broad immune response against multiple strains of H5N1 “bird flu”. The study, published today in the journal Nature Communications, highlights the potential of mucosal immunization strategies--where vaccines are squirted into the nostrils--to prime immune defenses against diverse influenza strains.
The spread of H5N1 influenza in animals with spillover into human ...
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person’s sense of reality. Now—just over a year after the first new schizophrenia drug in half a century was approved—a study in Nature Mental Health looks at how patients respond to it, offering early clues for more personalized treatment.
The study, led by Michael Halassa, professor of neuroscience at Tufts University School of Medicine, analyzed electronic medical records from 49 patients hospitalized for schizophrenia, schizoaffective disorder, or bipolar disorder ...
Type 1 Diabetes: Risk Differs Depending on Affected Family Member
Type 1 diabetes is an autoimmune disease in which the immune system destroys the body’s own insulin-producing beta-cells in the pancreas, leaving patients with a lifelong dependency on external insulin. Children whose parents or siblings have type 1 diabetes have an 8- to 15-fold increased risk of developing the autoimmune disease themselves. However, this risk is not evenly distributed: the child of a mother with type 1 diabetes has a lower risk of developing type 1 diabetes than a child with a father or sibling with type 1 diabetes. Of interest, ...
For over two years, the Austrian mini-satellite PRETTY has orbited the Earth at an altitude of just over 500 kilometres in a sun-synchronous polar orbit. Following the commissioning phase at the end of 2023, it provided continuous data on changes in polar ice and sea levels, as well as the effects of space weather on a satellite’s lifespan. Although the mission was originally planned to last one year, it is now certain that the mission of the satellite (jointly developed by TU Graz, Beyond Gravity Austria, and Seibersdorf Laboratories) will continue in a new form under the name OPS-SAT PRETTY. This has been confirmed by the Austrian ...
